Management of hypertension in the general out-patient clinics (GOPCs) of New Territories West Cluster: Yesterday, today and tomorrow

Hong Kong Practitioner

Volumn 29, Issue 12, 2007, Pages 470-480

  Chan, Laam ^a,b   Tsui, Pun Nang ^a   Ng, Yeung Shing ^a   Chan, Chi Hung ^a   Suen, Hong Ning ^a   To, Dorothy ^a   Liang, Jun ^a   Chan, Cynthia S Y ^a  

^a NTWC

^b TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MANAGED CARE; MEDICAL AUDIT; MEDICAL RECORD; ORGAN INJURY; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINE; PROFESSIONAL KNOWLEDGE; RISK ASSESSMENT; SCREENING TEST; SODIUM RESTRICTION; TEAMWORK; UNSPECIFIED SIDE EFFECT;

EID: 39549115878     PISSN: 10273948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Clinic Report on frequency of ICPC coding from computer management system (CMS) of NTWC for the period 2004 to 2006.
2. Ezzati M, Lopez AD, Rodgers A, et al. and the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-1360.
3. World Health Organization. The World Health Report 2002: Risks to Health 2002. Geneva: World Health Organization.
4. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-223.
5. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-1992.
6. Recommendation for Blood Pressure Measurement in Humans and Experimental Animals:Part 1: Blood Pressure Measurement in Humans: A statement for professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111;697-716.
7. Chobanian AV, Bakris GL, Black HR, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
8. Guideline committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053.
9. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-640.
10. 2004 Canadian Hypertension Education Program. Can J Card 2004.
11. The Heart Foundation Hypertension Management Guide for Doctors 2004.
12. Guideline Working Group. Guidelines for the management of essential hypertension in adults in primary care. Hospital Authority 2004.
13. Blood pressure control rate in the community is low. JAMA 2005; 294:466-472.
14. Wolf-Maier K, Cooper RS, Kramer H. Hypertension Treatment and Control in Five European Countries, Canada, and the United States. Hypertension 2004;43:10.
15. Cheung BM, Law FC, Lau CP. The rule of halves applies in Chinese hypertensive patients. Am J Hypertens 2002;15:209A.
16. Go D, Reynolds K, Wu X, et al. InterASIA Collaborative Group. The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002;40:920-927.
17. Annual Statistis Report of Hospital Authority 2004/05.
18. Lee A, Chan KK, Wun YT, et al. A morbidity survey in Hong Kong, 1994. HK Pract 1995;17:246-255.
19. Lam WK, Ho KY, Ng KK, et al. Morbidity pattern in four government general practice clinics using the International Classification of Primary Care (Revised Edition) (ICPC-2) coding. HK Pract 2006;28: 363-375.
20. Tsui PN. An evidence based clinical audit on process and outcome of management of isolated and uncomplicated hypertension in a primary care clinic.
21. Ng YS. Clinical Audit: management of uncomplicated hypertension in Yung fung Shee General Outpatient Clinic.
22. Chan L. A clinical audit on the management of uncomplicated hypertension in one general out patient clinic.
23. Ramsay L, Williams B, Johnston G, et al. Guidelines for management of hypertension report of the third working party of the British Hypertension Society, 1999. J Hum Hypertens 1999; 13.569-592.
24. Department of General Practice & Primary Health Care, University of Leicester (Eli Lilly). Management of Hypertension In Primary Care.
25. Hypertension Working Group (1999-2000). Department of Health Hypertension Protocol for GOPD.
26. NICE and the British Hypertension Society update 28 June 2006.
27. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol addding bendroflumethiaxide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOT-BPLA):a multicentre randomized controlled trial. Lancet 2005;366:895-906.
28. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-223.
29. He J, Klag MJ, Wu Z, et al. Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke. Stroke 1995;26: 2228-2232.
30. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998;352:1801-180.
31. He J, Whelton PK, Wu X, et al. Comparison of secular trends in prevalence of hypertension in the People's Republic of China and the United States of America. Am J Hypertens 1996;9:74A.
32. Prevalence of HT in older Australian population. J Hum Hypertens 2005;19:691-696.
33. Principles for Best Practice in Clinical Audit National institue for Clinical Excellence 2002
34. Patel R, Lawlor DA, Whincup P, et al. The detection, treatment and control of high blood pressure in older British adults: cross-sextional findings from the British Women's heart and Health Study and the British Regional heart Study. J Hum Hypertens 2006;20:733-741.
35. Chan NN, Tong C Y P, Chan C N J. Management of systemic hypertension: an update for primary care physician. HK Pract 2005;27:4-14.
36. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.